Boston Scientific Corp stock is traded at $43.13, with a volume of 2,385,096. It is down -3.38% in the last 24 hours and up +2.23% over the past month. Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Previous Close:
$44.64
Open:
$43.35
24h Volume:
2,385,096
Relative Volume:
0.09
Market Cap:
$62.52B
Revenue:
$20.62B
Net Income/Loss:
$3.56B
P/E Ratio:
18.09
EPS:
$2.38
Net Cash Flow:
$3.48B
1W Performance:
+2.74%
1M Performance:
+2.23%
6M Performance:
-22.98%
1Y Performance:
-56.46%
1-Day Range:
$42.93$43.63
1-Week Range:
$41.90$46.97
52-Week Range:
$39.57$105.65
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific CorpSector
HealthcareIndustry
Medical DevicesPhone
508-683-4000Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS